|
Shares | Weighted Average Grant Date Fair Value |
|||||
---|---|---|---|---|---|---|---|
Balance at February 27, 2010 |
5,944 | 2.26 | |||||
Granted |
4,574 | 1.07 | |||||
Vested |
(3,055 | ) | 3.21 | ||||
Cancelled |
(385 | ) | 1.65 | ||||
Balance at February 26, 2011 |
7,078 | 1.12 | |||||
Granted |
8,525 | 1.23 | |||||
Vested |
(3,366 | ) | 1.11 | ||||
Cancelled |
(731 | ) | 1.16 | ||||
Balance at March 3, 2012 |
11,506 | $ | 1.20 | ||||
Granted |
5,450 | 1.31 | |||||
Vested |
(3,917 | ) | 1.18 | ||||
Cancelled |
(362 | ) | 1.26 | ||||
Balance at March 2, 2013 |
12,677 | $ | 1.25 | ||||
|
Shares | Weighted Average Exercise Price Per Share |
Weighted Average Remaining Contractual Term |
Aggregate Intrinsic Value |
|||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Outstanding at February 27, 2010 |
76,114 | 3.08 | |||||||||||
Granted |
17,443 | 1.07 | |||||||||||
Exercised |
(244 | ) | 0.92 | ||||||||||
Cancelled |
(19,015 | ) | 3.66 | ||||||||||
Outstanding at February 26, 2011 |
74,298 | 2.47 | |||||||||||
Granted |
23,200 | 1.19 | |||||||||||
Exercised |
(896 | ) | 1.02 | ||||||||||
Cancelled |
(22,804 | ) | 4.31 | ||||||||||
Outstanding at March 3, 2012 |
73,798 | $ | 1.52 | ||||||||||
Granted |
12,020 | 1.32 | |||||||||||
Exercised |
(1,535 | ) | 1.06 | ||||||||||
Cancelled |
(3,283 | ) | 2.08 | ||||||||||
Outstanding at March 2, 2013 |
81,000 | $ | 1.48 | 6.79 | $ | 38,963 | |||||||
Vested or expected to vest at March 2, 2013 |
72,742 | $ | 1.51 | 6.66 | $ | 35,262 | |||||||
Exercisable at March 2, 2013 |
42,893 | $ | 1.71 | 5.75 | $ | 21,534 | |||||||
|
2013 | 2012 | 2011 | |||||||
---|---|---|---|---|---|---|---|---|---|---|
Expected stock price volatility(1) |
85 | % | 79 | % | 79 | % | ||||
Expected dividend yield(2) |
0.00 | % | 0.00 | % | 0.00 | % | ||||
Risk-free interest rate(3) |
0.71 | % | 1.45 | % | 1.92 | % | ||||
Expected option life(4) |
5.5 years | 5.5 years | 5.5 years |